Clinical Trials Browser

Myeloproliferative Disorders, Thrombocytosis, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT07469306 2026-03-13

Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer

Phase 2 Not yet recruiting

130 enrolled

Gastrointestinal

Locally Advanced Rectal Cancer

NCT07469956 2026-03-13

Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer

Phase 2 Not yet recruiting

30 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07471841 2026-03-13

Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received Venetoclax

Phase 2 Not yet recruiting

25 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07450976 2026-03-12

A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer

Phase 2 Not yet recruiting

151 enrolled

Gastrointestinal

Biliary Tract Neoplasms

NCT07452224 2026-03-12

ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung Cancer

Phase 2 Not yet recruiting

80 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07457164 2026-03-12

A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer

Phase 2 Not yet recruiting

40 enrolled

Genitourinary

Urogenital Diseases, Prostatic Diseases

NCT07465757 2026-03-12

ALISCA-Lung2

Phase 2 Not yet recruiting

50 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT07466303 2026-03-12

Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for Triple-Negative Breast Cancer

Phase 2 Not yet recruiting

84 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07466927 2026-03-12

Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With HER2-negative Breast Cancer With Liver Metastases

Phase 2 Not yet recruiting

30 enrolled

Breast

HER2-negative Breast Cancer

NCT07467590 2026-03-12

TRIUNITE-07

Phase 2 Not yet recruiting

33 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT07467772 2026-03-12

Ph 2 Elacestrant in ER Positive Uterine Sarcomas

Phase 2 Not yet recruiting

30 enrolled

GynecologicSarcoma

Adenosarcoma of the uterus, Sarcoma, Endometrial Stromal, Perivascular Epithelioid Cell Neoplasms

NCT05265052 2026-03-11

3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain

Phase 2 Not yet recruiting

177 enrolled

Cancer Pain

NCT07077083 2026-03-11

CAIX PET/CT

Phase 2 Not yet recruiting

10 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07164469 2026-03-11

Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma

Phase 2 Not yet recruiting

100 enrolled

Lymphoid

Hodgkin Disease

NCT07381634 2026-03-11

The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities

Phase 2 Not yet recruiting

134 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT07441837 2026-03-11

TeLuNa

Phase 2 Not yet recruiting

60 enrolled

Genitourinary

Prostatic Neoplasms

NCT07455955 2026-03-11

Personalized Antiemetic Regimen According to Patients' Pharmacogenetic Profile

Phase 2 Not yet recruiting

200 enrolled

Breast

Breast Neoplasms